HERV‐K TM Subunit Elicits CD8 + T Cell Anergy and Tumor Immune Evasion via Targeting CD3 Coreceptor ε in AML and PDAC
Advanced Science · 2026
DOI: 10.1002/advs.202417432 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Mengyuan Li und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology and Cancer Institute (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education), the Secon…. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal, Tumor Escape. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Major Research Plan of the National Natural Science Foundation of China, Natural Science Foundation of Zhejiang Province.
Abstract (Originalsprache)
CD8 + T cell anergy is a critical driver of cancer immune evasion, but the underlying causes and mechanisms remain elusive. Here, the functional human endogenous retroviruses‐K envelope (HERV‐K Env) subunit transmembrane (K‐TM) is identified as a potent viral immune checkpoint that induces CD8 + T cell anergy and elicits immune evasion in acute myeloid leukemia (AML) and pancreatic duct adenocarcinoma (PDAC). K‐TM subunits are highly expressed in CD8 + T cells and enriched in sera of cancer patients. K‐TM‐low CD8 + T cells show potent tumor‐killing ability, whereas K‐TM‐high CD8 + T cells are incapable of eliciting anti‐tumor effects. Both intracellular and extracellular K‐TM inhibit CD8 + T cell activation and cytokine release, leading to CD8 + T cell anergy. Mechanistically, K‐TM directly binds to the ITAM domain of CD3ε receptor via its transmembrane domain (TMD), inhibiting CD3ε phosphorylation and disabling TCR signaling. In mouse models, K‐TM reduces CD8 + T cell infiltration in tumor tissues and elicits immune evasion. Targeting K‐TM reverses CD8 + T cell anergy, restores T cell‐mediated tumor cell killing and regresses PDAC in animal model. The findings for the first time define viral immune checkpoint K‐TM subunit as potent driving force of immune evasion and represent a conceptually new target for immune therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology and Cancer Institute (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education), the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzho…
- Institute of Hematology, Zhejiang University, Hangzhou, 310009, China.
- Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310009, China.
- Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310009, China.
- MOE Joint International Research Laboratory of Pancreatic Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310009, China.
- Department of Hematology, The Affiliated People's Hospital of Ningbo University, Ningbo, 315000, China.
ORCID-Profile: Rongzhen Xu
Förderung
- National Natural Science Foundation of China
- Major Research Plan of the National Natural Science Foundation of China
- Natural Science Foundation of Zhejiang Province
Zitieren
APA
Li, M., Zheng, S., Gong, Q., Wu, Z., Lei, W., Cao, W., Wang, P., Zhang, X., Qian, W., Liang, Y., Lu, Y., Li, F., Zhang, Q., & Xu, R. (2026). HERV‐K TM Subunit Elicits CD8 + T Cell Anergy and Tumor Immune Evasion via Targeting CD3 Coreceptor ε in AML and PDAC. Advanced Science. https://doi.org/10.1002/advs.202417432
Vancouver
Li M, Zheng S, Gong Q, Wu Z, Lei W, Cao W, et al. HERV‐K TM Subunit Elicits CD8 + T Cell Anergy and Tumor Immune Evasion via Targeting CD3 Coreceptor ε in AML and PDAC. Advanced Science. 2026. doi:10.1002/advs.202417432
BibTeX
@article{Li2026,
author = {Li, Mengyuan and Zheng, Shuwen and Gong, Qinyuan and Wu, Zhaoxing and Lei, Wen and Cao, Wanyue and Wang, Ping and Zhang, Xuzhao and Qian, Wenbin and Liang, Yun and Lu, Ying and Li, Fenglin and Zhang, Qi and Xu, Rongzhen},
title = {HERV‐K TM Subunit Elicits CD8 + T Cell Anergy and Tumor Immune Evasion via Targeting CD3 Coreceptor ε in AML and PDAC},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.202417432}
}
EUVIMED